Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin‐SV40 T antigen transgenic rats

Transgenic rats containing the mouse albumin promoter and enhancer directing the expression of simian virus (SV40) T antigen (T Ag) exhibited a 100% incidence of hepatic neoplasms by 24–36 wk of age. These transgenic rats exhibited expression of large T Ag and c‐myc protein within focal basophilic lesions and nodules, but not in surrounding hepatocytes. At 24 wk of age, female TG+ rats exhibited a significantly greater number of lesions and a much greater percentage of the liver occupied by TG+ focal hepatic lesions than did their male TG+ littermates. Previous studies on these animals [Sargent et al., Cancer Res 1997;57:3451–3456] demonstrate that at 12 wk of age approximately one‐third of metaphases in hepatocytes exhibit a duplication of the 1q3.7‐1q4.1 region of rat chromosome 1, with the smallest common region of duplication being that of 1q4.1. Duplication of the 1q3.7‐1q4.3 region is also noted in many primary hepatic neoplasms resulting from the multistage model of Initiation‐Promotion‐Progression (IPP) [Sargent et al., Cancer Res 1996;56:2985–2991]. This region is syntenic with human 11p15.5 and mouse 7ter, which have been implicated in the development of specific neoplasms. Within the syntenic region was a cluster of imprinted genes whose expression we investigated in livers and neoplasms of TG+ rats. H19 was expressed in almost all of the neoplasms, but not in normal adult liver cells. Igf2 expression was detected in the majority of hepatic neoplasms of female TG+ rats, but in a relatively smaller number of neoplasms of TG+ males. The expression of p57Kip2 (Kip2), a cyclin‐dependent kinase inhibitor that was also in the imprinted region, exhibited some variable increased expression predominantly in hepatic neoplasms from livers of female TG+ rats. Other imprinted genes within the imprinted gene cluster—insulin II (Ins2), Mash2 (which codes for a basic helix‐loop‐helix transcription factor), and Kvlqt1 (coding for a component of a potassium transport channel)—showed no consistently different expression from that seen in normal hepatocytes. Another gene, also located on the long arm of chromosome 1, that showed changes was the ribonucleotide reductase M1 subunit (Rrm1), in which an increase in its expression was found. This was seen in hepatic neoplasms of TG+ rats of both sexes compared with surrounding normal‐appearing liver. Because hepatic neoplasms developing in livers of rats treated with chemical carcinogens commonly exhibit an increased expression of c‐myc mRNA, expression of this gene was investigated in focal lesions and livers of TG+ rats, although c‐myc was not located on chromosome 1. c‐myc mRNA was increased in focal lesions, nodules, and neoplasms in both male and female TG+ rats compared with adult and surrounding liver. Immunostaining for c‐myc protein demonstrated detectable levels in isolated single cells as well as focal lesions and neoplasms. Thus, the enhanced c‐myc expression, common to all hepatic neoplasms in this system, coupled with enhanced expression of Igf2 in female TG+ rats, may be responsible for the increase in growth rate in hepatic neoplasms of female TG+ rats compared with that in livers of male TG+ rats and may contribute to neoplastic progression in the liver of this transgenic model. Published 2004 Wiley‐Liss, Inc.

[1]  D. Sarli,et al.  Loss of parental‐specific methylation at the IGF2 locus in human hepatocellular carcinoma , 2003, The Journal of pathology.

[2]  H. Pitot,et al.  Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat , 2003, Molecular carcinogenesis.

[3]  E. Passamani,et al.  Ribonucleotide Reductase and Cell Proliferation , 2003 .

[4]  T. Dupressoir,et al.  Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. , 2002, Carcinogenesis.

[5]  A. Hochberg,et al.  Possible physiological role of H19 RNA , 2002, Molecular carcinogenesis.

[6]  A. Hoeflich,et al.  Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[7]  J. Pipas,et al.  Transforming functions of Simian Virus 40 , 2001, Oncogene.

[8]  G. Ramadori,et al.  The IGF axis and hepatocarcinogenesis , 2001, Molecular pathology : MP.

[9]  W. Reik,et al.  Genomic imprinting: parental influence on the genome , 2001, Nature Reviews Genetics.

[10]  C. Bruni,et al.  The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis , 2000, Oncogene.

[11]  E. Sandgren,et al.  Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. , 2000, The American journal of pathology.

[12]  K. Davies,et al.  Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse. , 2000, Human molecular genetics.

[13]  C. Croce,et al.  Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Berthold,et al.  Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors. , 2000, Human molecular genetics.

[15]  D. Simmons,et al.  SV40 large T antigen functions in DNA replication and transformation. , 2000, Advances in virus research.

[16]  K. Ochi,et al.  High frequency of inactivation of the imprinted H19 gene in “sporadic” hepatoblastoma , 1999, International journal of cancer.

[17]  Y. Morishita,et al.  Amplification of c-myc in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overexpression , 1999, Oncology.

[18]  S. Lottin,et al.  H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. , 1998, The American journal of pathology.

[19]  J. Foekens,et al.  Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures , 1998, FEBS letters.

[20]  A. Feinberg,et al.  Syntenic organization of the mouse distal chromosome 7 imprinting cluster and the Beckwith-Wiedemann syndrome region in chromosome 11p15.5. , 1998, Human molecular genetics.

[21]  M. Cleary,et al.  Multiple Mechanisms Regulate Imprinting of the Mouse Distal Chromosome 7 Gene Cluster , 1998, Molecular and Cellular Biology.

[22]  J. Rossant,et al.  Mash2 is expressed in oogenesis and preimplantation development but is not required for blastocyst formation , 1998, Mechanisms of Development.

[23]  Y. I. Lee,et al.  Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. , 1997, Cancer letters.

[24]  W. Held,et al.  Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice. , 1997, Cancer research.

[25]  T. Shirai.  Review Article: A Medium-Term Rat Liver Bioassay as a Rapid In Vivo Test for Carcinogenic Potential: A Historical Review of Model Development and Summary of Results from 291 Tests , 1997, Toxicologic pathology.

[26]  Y H Xu,et al.  Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms. , 1997, Cancer research.

[27]  A. Hochberg,et al.  H19 in normal development and neoplasia , 1997, Molecular reproduction and development.

[28]  R. Kraus,et al.  Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. , 1997, Molecular endocrinology.

[29]  V. Erdmann,et al.  The product of the imprinted H19 gene is an oncofetal RNA. , 1997, Molecular pathology : MP.

[30]  L. Gaspa,et al.  c‐myc amplification in pre‐malignant and malignant lesions induced in rat liver by the resistant hepatocyte model , 1996, International journal of cancer.

[31]  Y. Dragan,et al.  Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. , 1996, Cancer research.

[32]  Y. Dragan,et al.  Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. , 1996, Cancer research.

[33]  H C Pitot,et al.  Quantitation of Multistage Carcinogenesis in Rat Liver , 1996, Toxicologic pathology.

[34]  E. Farber,et al.  The step-by-step development of epithelial cancer: from phenotype to genotype. , 1996, Advances in cancer research.

[35]  M. Pazin,et al.  An enhancer deletion affects both H19 and Igf2 expression. , 1995, Genes & development.

[36]  G. Ciliberto,et al.  Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. , 1995, Oncogene.

[37]  S. Tilghman,et al.  Disruption of imprinting caused by deletion of the H19 gene region in mice , 1995, Nature.

[38]  A. Feinberg,et al.  Loss of imprinting in hepatoblastoma. , 1995, Cancer research.

[39]  N. Drinkwater,et al.  Genetic susceptibility to liver cancer , 1995 .

[40]  J. Green,et al.  Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Hermeking,et al.  Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Balmain,et al.  Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors , 1994, Molecular carcinogenesis.

[43]  J. Peterson,et al.  Transgenic hepatocarcinogenesis in the rat. , 1994, The American journal of pathology.

[44]  Y. Dragan,et al.  Biochemical events during initiation of rat hepatocarcinogenesis. , 1994, Carcinogenesis.

[45]  D. Hanahan,et al.  A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis , 1994, Nature.

[46]  Y. Dragan,et al.  The multistage nature of chemically induced hepatocarcinogenesis in the rat. , 1994, Drug metabolism reviews.

[47]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[48]  J. Ward,et al.  Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. , 1993, Cancer research.

[49]  G. Riou,et al.  Expression of the human fetal bac h19 gene in invasive cancers. , 1993, International journal of oncology.

[50]  M. Vazquez,et al.  Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. , 1993, Journal of medical genetics.

[51]  A. Caricasole,et al.  Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex. , 1993, Nucleic acids research.

[52]  Y H Xu,et al.  The Initiation-Promotion-Progression Model of Rat Hepatocarcinogenesis , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[53]  J. Sussenbach,et al.  Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors. , 1992, Cancer research.

[54]  A. Sandberg,et al.  Reviews on chromosome studies in urological tumors. I. Renal tumors. , 1992, The Journal of urology.

[55]  G. Fourel,et al.  Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Schirmacher,et al.  Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. , 1992, Cancer research.

[57]  F Poirier,et al.  The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. , 1991, Development.

[58]  C. Rogler,et al.  Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. , 1991, Carcinogenesis.

[59]  I. Hällström,et al.  Role of growth hormone in the regulation of the c‐myc gene during progression of sex‐differentiated rat liver carcinogenesis in the resistant hepatocyte model , 1991, Molecular carcinogenesis.

[60]  T. Tahira,et al.  Possible involvement of c‐myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats , 1991, Molecular carcinogenesis.

[61]  P. Chambon,et al.  Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex , 1990, Cell.

[62]  D. Jacobovitz,et al.  Immunohistochemical detection of c-myc and c-erbA products in diethylnitrosamine-induced preneoplastic and neoplastic liver lesions in rats. , 1990, Carcinogenesis.

[63]  T. Matsuguchi,et al.  Functional analysis of multiple promoters of the rat insulin-like growth factor II gene , 1990 .

[64]  W. Deppert,et al.  Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation. , 1989, Oncogene.

[65]  T. Matsuguchi,et al.  Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis. , 1988, Carcinogenesis.

[66]  S. Tilghman,et al.  The structure and expression of a novel gene activated in early mouse embryogenesis. , 1988, The EMBO journal.

[67]  Hidetoshi Takahashi,et al.  SPONTANEOUS OCCURRENCE OF PLACENTAL GLUTATHIONE S‐TRANSFERASE‐POSITIVE FOCI IN THE LIVERS OF LEC RATS , 1988, Japanese journal of cancer research : Gann.

[68]  M. Noguchi,et al.  Loss of genes on the short arm of chromosome 11 in human lung carcinomas. , 1987, Japanese journal of cancer research : Gann.

[69]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[70]  M. Soares,et al.  Rat insulin-like growth factor II gene. A single gene with two promoters expressing a multitranscript family. , 1986, Journal of molecular biology.

[71]  H. Pitot,et al.  Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. , 1986, Journal of the National Cancer Institute.

[72]  E. Mcconnell,et al.  National Toxicology Program Nomenclature for Hepatoproliferative Lesions of Rats , 1986, Toxicologic pathology.

[73]  K. Sato,et al.  Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[75]  D. Solt,et al.  New principle for the analysis of chemical carcinogenesis , 1976, Nature.

[76]  R. Squire,et al.  Report of a workshop on classification of specific hepatocellular lesions in rats. , 1975, Cancer research.

[77]  E. Passamani,et al.  Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. , 1970, The Journal of biological chemistry.

[78]  S. A. Saltikov.  THE DETERMINATION OF THE SIZE DISTRIBUTION OF PARTICLES IN AN OPAQUE MATERIAL FROM A MEASUREMENT OF THE SIZE DISTRIBUTION OF THEIR SECTIONS , 1967 .